Business Wire: September 13, 2016 – SOMERSET, NJ, U.S.A. – Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, today announced an agreement for Catalent, through its wholly owned…
